Kirk Fowers

1.9k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Kirk Fowers is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Kirk Fowers has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Hepatology. Recurrent topics in Kirk Fowers's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Glioma Diagnosis and Treatment (6 papers). Kirk Fowers is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Glioma Diagnosis and Treatment (6 papers). Kirk Fowers collaborates with scholars based in United States, Netherlands and Italy. Kirk Fowers's co-authors include Riad Salem, Siddharth A. Padia, Edward Kim, Guy E. Johnson, Robert J. Lewandowski, Éveline Boucher, Ahsun Riaz, V. Bishay, Jindřich Kopeček and Ramesh Rathi and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Hepatology.

In The Last Decade

Kirk Fowers

32 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

2021 289 citations Riad Salem, Guy E. Johnson et al. profile →

Peers

Countries citing papers authored by Kirk Fowers

Since Specialization

Citations

This map shows the geographic impact of Kirk Fowers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Fowers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Fowers more than expected).

Fields of papers citing papers by Kirk Fowers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Fowers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Fowers. The network helps show where Kirk Fowers may publish in the future.

Co-authorship network of co-authors of Kirk Fowers

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Fowers. A scholar is included among the top collaborators of Kirk Fowers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Fowers. Kirk Fowers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiation segmentectomy for early hepatocellular carcinoma is curative 2025 ·Journal of Hepatology ·Riad Salem, Siddharth A. Padia, Beau Toskich, (unknown), Kirk Fowers, (unknown), Guy E. Johnson, Laura Kulik, Tushar Patel, Robert J. Lewandowski, Edward Kim	4
2	SPECT/CT Dosimetry of Bronchial Artery ^99mTc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery ⁹⁰Y Radioembolization 2025 ·Radiology ·Eric Wehrenberg-Klee, Thomas J. An, Pedram Heidari, (unknown), Matthew R. Dreher, (unknown), Kirk Fowers, Jan Schuemann, Alejandro Bertolet	1
3	Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marnix G. E. H. Lam, Riad Salem, Beau Toskich, S. Cheenu Kappadath, Claudio Chiesa, Kirk Fowers, Paul Haste, Joseph M. Herman, Edward Kim, Thomas Leung, Siddharth A. Padia, Bruno Sangro, Daniel Y. Sze, Étienne Garin	0
4	Optimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety analyses from the EPOCH study 2024 ·The Oncologist ·Riad Salem, Étienne Garin, Éveline Boucher, Kirk Fowers, Marnix G. E. H. Lam, Siddharth A. Padia, William Proctor Harris	1
5	Using Voxel-Based Dosimetry to Evaluate Sphere Concentration and Tumor Dose in Hepatocellular Carcinoma Treated with Yttrium-90 Radiation Segmentectomy with Glass Microspheres 2024 ·Journal of Vascular and Interventional Radiology ·Tyler Sandow, Juan Gimenez, (unknown), (unknown), Patrick Gilbert, (unknown), (unknown), Kirk Fowers, Ari Cohen, Paul Thevenot	5
6	Utility of pre-procedural [99mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of 90Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [99mTc]TcMAA-based Segmentation 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marnix G. E. H. Lam, Étienne Garin, Paul Haste, Alban Denys, Brian Geller, S. Cheenu Kappadath, Cüneyt Türkmen, Daniel Y. Sze, (unknown), (unknown), Marco Maccauro, Murat Cantaşdemir, Matthew R. Dreher, Kirk Fowers, Vanessa L. Gates, Riad Salem	1
7	Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Étienne Garin, Xavier Palard-Novello, Armeen Mahvash, (unknown), Paul Haste, Mark Tann, Ken Herrmann, Francesco Barbato, Brian Geller, Niklaus Schaefer, Alban Denys, Matthew R. Dreher, Kirk Fowers, Vanessa L. Gates, Riad Salem	4
8	Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Riad Salem, Siddharth A. Padia, (unknown), Claudio Chiesa, Paul Haste, Bruno Sangro, Beau Toskich, Kirk Fowers, Joseph M. Herman, S. Cheenu Kappadath, Thomas Leung, Daniel Y. Sze, Edward Kim, Étienne Garin	64
9	A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Étienne Garin, Marco Maccauro, S. Cheenu Kappadath, Daniel Y. Sze, Cüneyt Türkmen, Murat Cantaşdemir, Paul Haste, Ken Herrmann, (unknown), Matthew R. Dreher, Kirk Fowers, Riad Salem	51
10	Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Riad Salem, Siddharth A. Padia, Marnix G. E. H. Lam, Jon Bell, Claudio Chiesa, Kirk Fowers, (unknown), Joseph M. Herman, S. Cheenu Kappadath, Thomas Leung, Lorraine Portelance, Daniel Y. Sze, Étienne Garin	89
11	EUS-guided paclitaxel injection as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation before surgery for localized or locoregional esophageal cancer: a multicenter prospective randomized trial 2016 ·Gastrointestinal Endoscopy ·John M. DeWitt, (unknown), (unknown), (unknown), Grzegorz Wallner, (unknown), Claire Daugherty, Kirk Fowers	15
12	DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy 2015 ·Journal of Materials Science Materials in Medicine ·Andrew L. Lewis, Matthew R. Dreher, Vincent OʼByrne, (unknown), (unknown), (unknown), Yiqing Tang, Brenda Hall, Kirk Fowers, (unknown), Karun Sharma, Bradford J. Wood	42
13	In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis 2012 ·Journal of Controlled Release ·Christi M. Terry, (unknown), Huan Li, (unknown), Donald Blumenthal, Seong‐Eun Kim, Shawn C. Owen, Eugene Kholmovski, Kirk Fowers, Ramesh Rathi, Alfred K. Cheung	30
14	Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model 2012 ·Journal of Neuro-Oncology ·Ananth K. Vellimana, Violette Renard Recinos, Lee Hwang, Kirk Fowers, Khan W. Li, Yonggang Zhang, (unknown), Charles G. Eberhart, Henry Brem, Betty Tyler	68
15	Targeting of Multidrug‐Resistant Human Ovarian Carcinoma Cells With Anti‐P‐Glycoprotein Antibody Conjugates 2012 ·Macromolecular Bioscience ·Kirk Fowers, Jindřich Kopeček	19
16	532 Multicenter, Prospective Randomized Phase IIB Study of Endoscopic Ultrasound Guided Intratumoral Injection of OncoGel™ (Regel™/Paclitaxel) As a Component of Neoadjuvant Chemoradiotherapy for Local or Loco-Regional Operable Esophageal Cancer - Interim Safety Results 2011 ·Gastrointestinal Endoscopy ·John M. DeWitt, (unknown), (unknown), Č Neoral, (unknown), (unknown), Marek Kamiński, Grzegorz Wallner, (unknown), Claire Daugherty, Kirk Fowers	2
17	Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer 2009 ·Anti-Cancer Drugs ·(unknown), Dino Tarabar, (unknown), (unknown), Kirk Fowers	62
18	OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system 2009 ·Advanced Drug Delivery Reviews ·(unknown), Kirk Fowers	217
19	Specific inhibition of C3 to facilitate general complement inhibition on endotoxin affinity sorbents for apheresis applications 2001 ·Biomaterials ·Kirk Fowers, Jarmila Janatova	1
20	Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance 2000 ·Biomaterials ·Monica Tijerina, Kirk Fowers, Pavla Kopečková, Jindřich Kopeček	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact